Archive Category: 10X Stocks Archive

Based on some limited polling, I know that many of you 10Xers out there are either entrepreneurs, high-level professionals, or have experience working at the executive level. So I’d like to start today’s update off with a hypothetical that takes advantage of some of that experience… Let’s pretend for just a moment that we’re all sitting at a corporate board meeting — all 12,238 paid-up 10Xers around the same gigantic conference table.

Markets will close at 1:00 p.m. ET this afternoon in anticipation of the upcoming Fourth of July holiday weekend, so I’ll keep this update brief… 2025 is shaping up to be a banner year for our 10X Stocks strategy… In the model portfolio, we have five positions with triple-digit open gains, with two (HIMS and SMR) around the halfway point to 10X gains.

Earlier this week, pharmaceutical giant Novo Nordisk (NVO) abruptly bailed on its landmark deal with Hims & Hers — even though it’s been less than two months since the deal was first announced. HIMS stock crashed almost 35% on Monday following news that Novo would no longer allow Hims & Hers to sell its popular GLP-1 weight-loss treatment, Wegovy.

Markets are closed today in observance of “Juneteenth,” commemorating the day on which America’s last slaves were set free more than 160 years ago. The holiday is a welcome break in the middle of what’s been a very eventful year for investors. We’ve already seen incredible gains for stocks like Hims & Hers Health (HIMS) and Centrus Energy (LEU) in the first half of 2025 — and I’m expecting even more great opportunities in the second half of the year…

As I trust you’ve learned by now, the entire Money & Markets team is on the nuclear renaissance trend like white on rice.